Chinese General Practice ›› 2022, Vol. 25 ›› Issue (32): 4010-4017.DOI: 10.12114/j.issn.1007-9572.2022.0355
Special Issue: 跌倒最新文章合集; 老年问题最新文章合集
• Article • Previous Articles Next Articles
Received:
2022-03-26
Revised:
2022-07-26
Published:
2022-11-15
Online:
2022-08-04
Contact:
WANG Qing
About author:
通讯作者:
王青
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0355
项目 | 死亡患者(n=130) | 非死亡患者(n=526) | 检验统计量值 | P值 | |
---|---|---|---|---|---|
年龄(岁) | 87.3±5.0 | 82.5±6.0 | -8.094 | <0.001 | |
性别(男/女) | 86/44 | 313/213 | 1.933b | 0.164 | |
BMI(kg/m2) | 23.0±4.0 | 24.1±3.6 | 3.709a | 0.002 | |
步速〔M(P25,P75),m/s〕 | 0.5(0.3,0.6) | 0.7(0.5,1.0) | -8.570 | <0.001 | |
握力〔M(P25,P75),kg〕 | |||||
男性 | 19.6(13.7,24.5) | 26.3(21.7,30.9) | -7.601 | <0.001 | |
女性 | 12.4(7.4,18.4) | 17.3(14.4,20.9) | -4.291 | <0.001 | |
合并疾病〔n(%)〕 | |||||
高血压 | 110(84.6) | 418(79.5) | 1.759b | 0.185 | |
冠心病 | 61(46.9) | 189(35.9) | 5.399b | 0.021 | |
脑卒中 | 77(59.2) | 247(47.0) | 6.281b | 0.012 | |
糖尿病 | 55(42.3) | 207(39.4) | 0.379b | 0.538 | |
慢性肾脏病 | 51(39.3) | 114(21.7) | 20.091b | <0.001 | |
慢性阻塞性肺疾病 | 37(28.5) | 110(20.9) | 3.416b | 0.065 | |
CCI〔M(P25,P75)〕 | 8.0(7.0,10.0) | 7.0(6.0,9.0) | -6.226 | <0.001 | |
营养不良(风险)〔n(%)〕 | 62(47.7) | 151(28.7) | 17.135b | <0.001 | |
日常生活活动能力下降〔n(%)〕 | 107(82.3) | 236(44.9) | 58.571b | <0.001 | |
认知功能障碍〔n(%)〕 | 52(40.0) | 89(16.9) | 32.906b | <0.001 | |
多重用药〔n(%)〕 | 62(47.7) | 206(39.2) | 3.138b | 0.076 | |
血红蛋白(g/L) | 116.1±18.2 | 127.3±17.4 | 6.476a | <0.001 | |
eGFR〔ml·min-1·1.73(m2)-1〕 | 72.3±32.1 | 79.8±24.3 | -3.561a | <0.001 |
Table 1 Comparison of clinical data between the deceased and survived patients
项目 | 死亡患者(n=130) | 非死亡患者(n=526) | 检验统计量值 | P值 | |
---|---|---|---|---|---|
年龄(岁) | 87.3±5.0 | 82.5±6.0 | -8.094 | <0.001 | |
性别(男/女) | 86/44 | 313/213 | 1.933b | 0.164 | |
BMI(kg/m2) | 23.0±4.0 | 24.1±3.6 | 3.709a | 0.002 | |
步速〔M(P25,P75),m/s〕 | 0.5(0.3,0.6) | 0.7(0.5,1.0) | -8.570 | <0.001 | |
握力〔M(P25,P75),kg〕 | |||||
男性 | 19.6(13.7,24.5) | 26.3(21.7,30.9) | -7.601 | <0.001 | |
女性 | 12.4(7.4,18.4) | 17.3(14.4,20.9) | -4.291 | <0.001 | |
合并疾病〔n(%)〕 | |||||
高血压 | 110(84.6) | 418(79.5) | 1.759b | 0.185 | |
冠心病 | 61(46.9) | 189(35.9) | 5.399b | 0.021 | |
脑卒中 | 77(59.2) | 247(47.0) | 6.281b | 0.012 | |
糖尿病 | 55(42.3) | 207(39.4) | 0.379b | 0.538 | |
慢性肾脏病 | 51(39.3) | 114(21.7) | 20.091b | <0.001 | |
慢性阻塞性肺疾病 | 37(28.5) | 110(20.9) | 3.416b | 0.065 | |
CCI〔M(P25,P75)〕 | 8.0(7.0,10.0) | 7.0(6.0,9.0) | -6.226 | <0.001 | |
营养不良(风险)〔n(%)〕 | 62(47.7) | 151(28.7) | 17.135b | <0.001 | |
日常生活活动能力下降〔n(%)〕 | 107(82.3) | 236(44.9) | 58.571b | <0.001 | |
认知功能障碍〔n(%)〕 | 52(40.0) | 89(16.9) | 32.906b | <0.001 | |
多重用药〔n(%)〕 | 62(47.7) | 206(39.2) | 3.138b | 0.076 | |
血红蛋白(g/L) | 116.1±18.2 | 127.3±17.4 | 6.476a | <0.001 | |
eGFR〔ml·min-1·1.73(m2)-1〕 | 72.3±32.1 | 79.8±24.3 | -3.561a | <0.001 |
项目 | 跌倒患者(n=147) | 未跌倒患者(n=509) | 检验统计量值 | P值 | |
---|---|---|---|---|---|
年龄(岁) | 84.0±6.3 | 83.2±6.1 | -1.384a | 0.167 | |
性别(男/女) | 80/67 | 319/190 | 3.258b | 0.071 | |
BMI(kg/m2) | 23.9±3.8 | 23.9±3.7 | 0.130a | 0.897 | |
步速〔M(P25,P75),m/s〕 | 0.6(0.4,0.8) | 0.7(0.5,0.9) | -2.735 | 0.006 | |
握力〔M(P25,P75),kg〕 | |||||
男性 | 21.7(16.9,26.3) | 26.1(20.6,31.9) | -1.128 | 0.045 | |
女性 | 13.9(11.0,16.7) | 17.7(13.0,21.2) | -2.076 | 0.017 | |
合并疾病〔n(%)〕 | |||||
高血压 | 121(82.3) | 407(80.0) | 0.402b | 0.526 | |
冠心病 | 63(42.9) | 187(36.7) | 1.810b | 0.178 | |
脑卒中 | 75(51.0) | 249(48.9) | 0.201b | 0.654 | |
糖尿病 | 60(40.8) | 202(39.7) | 0.601b | 0.805 | |
慢性肾脏病 | 42(28.6) | 122(24.0) | 1.551b | 0.460 | |
慢性阻塞性肺疾病 | 35(23.8) | 112(22.0) | 0.214b | 0.644 | |
CCI〔M(P25,P75)〕 | 8.0(6.0,9.0) | 7.0(6.0,9.0) | -1.611 | 0.107 | |
营养不良(风险)〔n(%)〕 | 61(41.5) | 152(29.9) | 7.041b | 0.008 | |
日常生活活动能力下降〔n(%)〕 | 89(60.5) | 254(49.9) | 5.178b | 0.023 | |
认知功能障碍〔n(%)〕 | 39(26.5) | 102(20.0) | 2.848b | 0.191 | |
多重用药〔n(%)〕 | 64(43.5) | 204(40.1) | 0.565b | 0.452 | |
血红蛋白(g/L) | 123.3±18.3 | 125.6±18.1 | 1.328a | 0.185 | |
eGFR〔ml·min-1·1.73(m2)-1〕 | 80.0±26.0 | 77.9±26.2 | -0.866a | 0.387 |
Table 2 Comparison of clinical data between patients with and without a fall
项目 | 跌倒患者(n=147) | 未跌倒患者(n=509) | 检验统计量值 | P值 | |
---|---|---|---|---|---|
年龄(岁) | 84.0±6.3 | 83.2±6.1 | -1.384a | 0.167 | |
性别(男/女) | 80/67 | 319/190 | 3.258b | 0.071 | |
BMI(kg/m2) | 23.9±3.8 | 23.9±3.7 | 0.130a | 0.897 | |
步速〔M(P25,P75),m/s〕 | 0.6(0.4,0.8) | 0.7(0.5,0.9) | -2.735 | 0.006 | |
握力〔M(P25,P75),kg〕 | |||||
男性 | 21.7(16.9,26.3) | 26.1(20.6,31.9) | -1.128 | 0.045 | |
女性 | 13.9(11.0,16.7) | 17.7(13.0,21.2) | -2.076 | 0.017 | |
合并疾病〔n(%)〕 | |||||
高血压 | 121(82.3) | 407(80.0) | 0.402b | 0.526 | |
冠心病 | 63(42.9) | 187(36.7) | 1.810b | 0.178 | |
脑卒中 | 75(51.0) | 249(48.9) | 0.201b | 0.654 | |
糖尿病 | 60(40.8) | 202(39.7) | 0.601b | 0.805 | |
慢性肾脏病 | 42(28.6) | 122(24.0) | 1.551b | 0.460 | |
慢性阻塞性肺疾病 | 35(23.8) | 112(22.0) | 0.214b | 0.644 | |
CCI〔M(P25,P75)〕 | 8.0(6.0,9.0) | 7.0(6.0,9.0) | -1.611 | 0.107 | |
营养不良(风险)〔n(%)〕 | 61(41.5) | 152(29.9) | 7.041b | 0.008 | |
日常生活活动能力下降〔n(%)〕 | 89(60.5) | 254(49.9) | 5.178b | 0.023 | |
认知功能障碍〔n(%)〕 | 39(26.5) | 102(20.0) | 2.848b | 0.191 | |
多重用药〔n(%)〕 | 64(43.5) | 204(40.1) | 0.565b | 0.452 | |
血红蛋白(g/L) | 123.3±18.3 | 125.6±18.1 | 1.328a | 0.185 | |
eGFR〔ml·min-1·1.73(m2)-1〕 | 80.0±26.0 | 77.9±26.2 | -0.866a | 0.387 |
自变量 | 单因素分析 | 多因素分析 | |||
---|---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | ||
步速 | |||||
T1组 | 7.16(3.98,12.88) | <0.01 | 2.50(1.24,5.07) | 0.011 | |
T2组 | 2.81(1.49,5.31) | <0.01 | 1.33(0.66,2.70) | 0.428 | |
T3组 | 1.00 | — | 1.00 | — | |
握力 | |||||
L1组 | 6.68(3.89,12.11) | <0.01 | 2.17(1.14,4.10) | 0.018 | |
L2组 | 2.36(1.27,4.38) | <0.01 | 1.37(0.72,2.61) | 0.314 | |
L3组 | 1.00 | — | 1.00 | — |
Table 3 The association of gait speed and grip strength with all-cause mortality by Cox regression analysis
自变量 | 单因素分析 | 多因素分析 | |||
---|---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | ||
步速 | |||||
T1组 | 7.16(3.98,12.88) | <0.01 | 2.50(1.24,5.07) | 0.011 | |
T2组 | 2.81(1.49,5.31) | <0.01 | 1.33(0.66,2.70) | 0.428 | |
T3组 | 1.00 | — | 1.00 | — | |
握力 | |||||
L1组 | 6.68(3.89,12.11) | <0.01 | 2.17(1.14,4.10) | 0.018 | |
L2组 | 2.36(1.27,4.38) | <0.01 | 1.37(0.72,2.61) | 0.314 | |
L3组 | 1.00 | — | 1.00 | — |
自变量 | 单因素分析 | 多因素分析 | |||
---|---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | ||
步速 | |||||
T1组 | 2.12(1.40,3.19) | <0.01 | 1.64(1.12,3.38) | 0.024 | |
T2组 | 1.37(0.89,2.11) | 0.152 | 1.12(0.70,1.79) | 0.316 | |
T3组 | 1.00 | — | 1.00 | — | |
握力 | |||||
L1组 | 1.87(1.23,2.83) | <0.01 | 1.36(0.84,2.20) | 0.261 | |
L2组 | 1.41(0.93,2.15) | 0.117 | 1.25(0.80,1.93) | 0.470 | |
L3组 | 1.00 | — | 1.00 | — |
Table 4 The association of gait speed and grip strength with falls by Cox regression analysis
自变量 | 单因素分析 | 多因素分析 | |||
---|---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | ||
步速 | |||||
T1组 | 2.12(1.40,3.19) | <0.01 | 1.64(1.12,3.38) | 0.024 | |
T2组 | 1.37(0.89,2.11) | 0.152 | 1.12(0.70,1.79) | 0.316 | |
T3组 | 1.00 | — | 1.00 | — | |
握力 | |||||
L1组 | 1.87(1.23,2.83) | <0.01 | 1.36(0.84,2.20) | 0.261 | |
L2组 | 1.41(0.93,2.15) | 0.117 | 1.25(0.80,1.93) | 0.470 | |
L3组 | 1.00 | — | 1.00 | — |
自变量 | 全因死亡 | 跌倒 | |||
---|---|---|---|---|---|
步速分组 | 握力分组 | HR(95%CI) | P值 | HR(95%CI) | P值 |
T3组 | L3组 | 1.00 | — | 1.00 | — |
T3组 | L2组 | 0.73 (0.17,3.11) | 0.672 | 1.29(0.63,2.64) | 0.489 |
T3组 | L1组 | 2.28(0.59,8.80) | 0.232 | 1.39(0.51,3.81) | 0.522 |
T2组 | L3组 | 1.18(0.33,4.21) | 0.797 | 1.32 (0.63,2.78) | 0.457 |
T2组 | L2组 | 1.11(0.35,3.48) | 0.859 | 1.24(0.63,2.44) | 0.540 |
T2组 | L1组 | 2.53(0.87,7.38) | 0.089 | 1.36(0.65,2.84) | 0.421 |
T1组 | L3组 | 1.69(0.43,6.69) | 0.454 | 1.16(0.43,3.09) | 0.770 |
T1组 | L2组 | 3.09(1.08,8.85) | 0.036 | 1.85(0.91,3.76) | 0.088 |
T1组 | L1组 | 3.29(1.13,9.55) | 0.028 | 1.92(1.13,4.27) | 0.032 |
Table 5 The association of the combination of gait speed and grip strength with all-mortality and falls by Cox regression analysis
自变量 | 全因死亡 | 跌倒 | |||
---|---|---|---|---|---|
步速分组 | 握力分组 | HR(95%CI) | P值 | HR(95%CI) | P值 |
T3组 | L3组 | 1.00 | — | 1.00 | — |
T3组 | L2组 | 0.73 (0.17,3.11) | 0.672 | 1.29(0.63,2.64) | 0.489 |
T3组 | L1组 | 2.28(0.59,8.80) | 0.232 | 1.39(0.51,3.81) | 0.522 |
T2组 | L3组 | 1.18(0.33,4.21) | 0.797 | 1.32 (0.63,2.78) | 0.457 |
T2组 | L2组 | 1.11(0.35,3.48) | 0.859 | 1.24(0.63,2.44) | 0.540 |
T2组 | L1组 | 2.53(0.87,7.38) | 0.089 | 1.36(0.65,2.84) | 0.421 |
T1组 | L3组 | 1.69(0.43,6.69) | 0.454 | 1.16(0.43,3.09) | 0.770 |
T1组 | L2组 | 3.09(1.08,8.85) | 0.036 | 1.85(0.91,3.76) | 0.088 |
T1组 | L1组 | 3.29(1.13,9.55) | 0.028 | 1.92(1.13,4.27) | 0.032 |
项目 | 全因死亡 | 跌倒 | ||||||
---|---|---|---|---|---|---|---|---|
最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) | 最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) | |
步速 | 0.64 | 0.742(0.697,0.788) | 76.2 | 62.6 | 0.57 | 0.682(0.640,0.723) | 75.1 | 45.6 |
握力 | 21.50 | 0.702(0.652,0.751) | 74.6 | 54.4 | 19.70 | 0.657(0.614,0.700) | 66.6 | 55.8 |
Table 6 Related variables of gait speed,grip strength,and their combination for predicting all-cause mortality and falls in geriatric inpatients
项目 | 全因死亡 | 跌倒 | ||||||
---|---|---|---|---|---|---|---|---|
最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) | 最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) | |
步速 | 0.64 | 0.742(0.697,0.788) | 76.2 | 62.6 | 0.57 | 0.682(0.640,0.723) | 75.1 | 45.6 |
握力 | 21.50 | 0.702(0.652,0.751) | 74.6 | 54.4 | 19.70 | 0.657(0.614,0.700) | 66.6 | 55.8 |
[1] |
董冰茹,顾杰. 社区老年人衰弱评估方法的研究进展[J]. 中国全科医学,2021,24(10):1302-1308. DOI:10.12114/j.issn.1007-9572.2021.00.012.
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
宋倩,孟文文,姜威,等. 社区老年人步速、握力与跌倒风险的前瞻性队列研究[J]. 中华保健医学杂志,2020,22(3):112-114. DOI:10.3969/j.issn.1674-3245.2020.03.003.
|
[9] |
全国eGFR课题协作组. MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. DOI:10.3760/j.issn:1001-7097.2006.10.002.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
蹇在金,王翼. 老年人多重用药的评估与干预[J]. 中华老年医学杂志,2019,38(10):1097-1100. DOI:10.3760/cma.j.issn.0254-9026.2019.10.010.
|
[15] |
|
[16] |
|
[17] |
中华医学会老年医学分会老年康复学组,肌肉衰减综合征专家共识撰写组. 肌肉衰减综合征中国专家共识(草案)[J]. 中华老年医学杂志,2017,36(7):711-718. DOI:10.3760/cma.j.issn.0254-9026.2017.07.001.
|
[18] |
|
[19] |
|
[20] |
杨卉,王青,路菲,等. 步速与住院高龄老年患者全因死亡的相关性[J]. 中华老年多器官疾病杂志,2021,20(5):332-336. DOI:10.11915/j.issn.1671-5403.2021.05.069.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
World Health Organization.Integrated caring for older people,ICOPE[EB/OL]. [2022-01-02].
|
[1] | FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358. |
[2] | GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238. |
[3] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[4] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[5] | WANG Yu, CHEN Yan, HAN Yuanyuan, XU Qing, CHEN Shengyue, LYU Zhibo, LU Chuan, ZHENG Mingxin, ZHAO Xin. Platelet-lymphocyte Ratio Predicts In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(33): 4137-4142. |
[6] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[7] | ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang. Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(32): 4038-4042. |
[8] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[9] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[10] | CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun. Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(31): 3890-3895. |
[11] | ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889. |
[12] | DUAN Yanqin, PENG Ying, LIU Shenglan, LIU Haijiao, YANG Huiqiong, HU Haiqing. Prevalence and Associated Factors of Potentially Inappropriate Medication among Elderly Outpatients [J]. Chinese General Practice, 2023, 26(31): 3902-3907. |
[13] | WEN Wen, ZHANG Kainan, CHEN Yulan, LI Yu, ZHANG Xiangyang. Correlation of Metabolic Indexes as Predictors with Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3740-3747. |
[14] | ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun. Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3815-3822. |
[15] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||